Information Technology·Application Software·$16.3B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.04 | N/A | -42.86% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.04 | N/A | -42.86% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management expressed concern over current market conditions impacting performance. They remain committed to strategic initiatives for future growth.
Management acknowledged challenges in meeting earnings expectations.
They emphasized a focus on long-term growth despite short-term setbacks.
PTC Inc's earnings report indicates a disappointing quarter, particularly with the EPS falling short of expectations. The stock's slight decline of 0.38% reflects investor reaction to the missed earnings. Without guidance for the future, investors may remain cautious about the company's short-term outlook.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
VERTEX PHARMACEUTICA
Oct 25, 2010